Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin.
Barnard DL, Day CW, Bailey K, Heiner M, Montgomery R, Lauridsen L, Winslow S, Hoopes J, Li JK, Lee J, Carson DA, Cottam HB, Sidwell RW.
Barnard DL, et al. Among authors: day cw.
Antiviral Res. 2006 Aug;71(1):53-63. doi: 10.1016/j.antiviral.2006.03.001. Epub 2006 Mar 24.
Antiviral Res. 2006.
PMID: 16621037
Free PMC article.